IHM
ALXN

Iguana Healthcare Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Iguana Healthcare Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,000
Closed -$3.04M – 81
2017
Q2 		$3.04M Hold
25,000
– – 1.72% 22
2017
Q1 		$3.03M Buy
+25,000
New +$3.22M 1.5% 21
2016
Q3 		– Sell
-50,000
Closed -$5.84M – 108
2016
Q2 		$5.84M Buy
+50,000
New +$7.09M 2.37% 12

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's ALXN Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Alexion Pharmaceuticals (ALXN) in Q1 2018: 27,500 shares worth $3.06M. The stake represents 2.02% of the portfolio and ranks #17 among its holdings. This is a return to the name: Iguana Healthcare Management previously reported a position in ALXN as recently as Q3 2017.

Iguana Healthcare Management first reported a position in ALXN in Q1 2014 and has held it in 9 quarters since. The position peaked at $18.4M in Q3 2016. 597 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

  • Iguana Healthcare Management held 27,500 shares of Alexion Pharmaceuticals worth $3.06M as of Q1 2018.
  • Alexion Pharmaceuticals was a new Iguana Healthcare Management position in Q1 2018.
  • Alexion Pharmaceuticals made up 2.02% of Iguana Healthcare Management's portfolio in Q1 2018, its #17 holding.
  • Iguana Healthcare Management first reported a position in Alexion Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
  • Iguana Healthcare Management's Alexion Pharmaceuticals position peaked at $18.4M in Q3 2016.
  • 597 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.